BioCryst announces acceptance of regulatory applications for Orladeyo (berotralstat) by Health Canada and Swissmedic

25 August 2021 - BioCryst Pharmaceuticals today announced that the new drug submission for Orladeyo (berotralstat) has been accepted for ...

Read more →

Clovis Oncology announces availability of and reimbursement for Rubraca (rucaparib) tablets for women with relapsed ovarian cancer in Switzerland

24 August 2021 - Rubraca is commercially available in Germany, United Kingdom, Italy, Spain, France, Netherlands, United States of America and ...

Read more →

BeiGene announces acceptance by Swissmedic of marketing authorisation application for Brukinsa (zanubrutinib) in Waldenström’s macroglobulinaemia

18 August 2021 - BeiGene announced that Swissmedic has accepted the marketing authorisation application for Brukinsa, a treatment option for adult ...

Read more →

Moderna COVID-19 vaccine gets Swiss approval for 12 to 17 year-olds

9 August 2021 - Swissmedic has approved the Moderna COVID-19 vaccine for 12- to 17-year-olds, the Swiss agency said on ...

Read more →

Emmaus Life Sciences announces submission of marketing authorisation application to Swissmedic; Ideogen to manage early access program

15 June 2021 - Emmaus Life Sciences anounced today it has received confirmation from the Swiss Agency for Therapeutic Products ...

Read more →

Moderna seeks vaccine approval for adolescents

11 June 2021 - US-based biotech company Moderna is applying for the use of its COVID-19 vaccine for adolescents aged 12 ...

Read more →

Switzerland ‘unfortunately’ still awaiting AstraZeneca COVID-19 vaccine data

21 April 2021 - Switzerland’s drug regulator is still awaiting data needed to consider whether to approve AstraZeneca’s COVID-19 vaccine, ...

Read more →

CureVac Swiss initiates rolling submission process for mRNA-based COVID-19 vaccine candidate, CVnCoV, with Swissmedic

19 April 2021 - Review process started with submission of first CVnCoV data package. ...

Read more →

Johnson & Johnson Covid vaccine approved for use in Switzerland

22 March 2021 - Health regulator Swissmedic has given the green light for the use of the vaccine produced by Johnson ...

Read more →

Data on AstraZeneca vaccine insufficient for Swiss approval

18 March 2021 - The medicines regulator Swissmedic says it has not yet received enough robust data from clinical trials ...

Read more →

Switzerland could sell or give away AstraZeneca doses if regulator dithers

21 February 2021 - A lack of green light from medicines regulator SwissMedic could see 5.3 million doses ordered by Switzerland ...

Read more →

Swiss medical regulator rejects Oxford/AstraZeneca COVID-19 vaccine

3 February 2021 - Switzerland’s medical regulator has said it cannot authorise use of the Oxford/AstraZeneca Covid-19 vaccine based on ...

Read more →

Swissmedic authorises COVID-19 Vaccine Moderna for use in Switzerland

12 January 2021 - Swiss Federal Government has secured 7.5 million doses and first deliveries expected to begin in January. ...

Read more →

MorphoSys and Incyte announce the acceptance of the Swissmedic marketing authorisation application for tafasitamab

5 January 2021 - The Swissmedic marketing authorisation application seeks approval for tafasitamab in combination with lenalidomide for the treatment ...

Read more →

Swissmedic approves Buvidal for the treatment of opioid dependence

18 December 2020 - Camurus announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal ...

Read more →